蒲地蓝消炎口服液预防妇产科术后感染临床疗效观察

发布时间：2018-06-18 04:51

  本文选题：蒲地蓝消炎口服液 + 妇科　； 参考：《中华医院感染学杂志》2015年18期

【摘要】：目的观察蒲地蓝消炎口服液预防妇产科术后感染的临床疗效,以降低术后感染的发生。方法选取2012年1月-2013年1月医院的200例妇产科手术患者,随机分为试验组和对照组,各100例;两组患者均给予常规抗菌药物治疗,治疗组在常规抗菌药物治疗基础上口服蒲地蓝消炎口服液,评价两组患者的临床疗效。结果试验组总有效率为98.0%,显著高于对照组的85.0%,差异有统计学意义(χ2=10.865,P0.05);试验组患者术后平均最高体温为(37.1±0.2)℃,对照组为(38.0±0.5)℃,两组差异有统计学意义(P0.05);试验组退热时间为(42.8±7.8)h,对照组为(43.4±9.1)h,差异无统计学意义;术后发病率试验组为2.0%、对照组为9.0%,两组差异有统计学意义(P0.05);两组患者切口甲级愈合率均为100.0%,无一例切口感染发生;两组患者在术后出现轻微泌尿道刺激症,试验组为3.0%,对照组为4.0%,两组比较差异无统计学意义,且尿常规或尿素氮化验结果均无异常。结论蒲地蓝消炎口服液联合抗菌药物治疗相较于单用抗菌药物治疗更能提高妇产科术后患者的生活质量,且安全、有效。
[Abstract]:Objective to observe the clinical effect of Pudilan Xiaoyan oral liquid in preventing postoperative infection in obstetrics and gynecology, and to reduce the incidence of postoperative infection. Methods from January 2012 to January 2013, 200 patients undergoing gynaecology and obstetrics surgery were randomly divided into two groups: the experimental group and the control group, 100 patients in each group were treated with routine antimicrobial agents. In the treatment group, the clinical efficacy of the two groups was evaluated by oral administration of Pudilan Xiaoyan liquid on the basis of routine antimicrobial therapy. Results the total effective rate of the trial group was 98.0, which was significantly higher than that of the control group (85.0) (蠂 ~ 2 + 10.865) P 0.05 (蠂 ~ 2 + 10.865), the average maximum body temperature after operation was 37.1 卤0.2 鈩，

本文编号：2034170